Books and Book Chapters

  1. Lopalco PL, Tozzi AE. Epidemiologia Facile. 2003. Pensiero Scientifico Editore, Roma
  2. Salisbury DM, Martin RM, Van Damme P, Lopalco PL. Chapter 68 – Immunization in Europe, Pages 1334-1352, in Vaccines, 6th Edition. 2013. Edited by Plotkin S, Orenstein WA, and Offit P. Elsevier inc. London
  3. Lopalco PL. Malattie infettive emergenti e riemergenti, in Manuale critico di sanità pubblica. 2015. A cura di Calamo-Specchia F. Maggioli Editore, Santarcangelo di Romagna (RN)
  4. Lopalco PL. L’Organizzazione Mondiale della Sanità, in Manuale critico di sanità pubblica. 2015. A cura di Calamo-Specchia F. Maggioli Editore, Santarcangelo di Romagna (RN)
  5. Lopalco PL. Valutazione del rischio, in Manuale critico di sanità pubblica. 2015. A cura di Calamo-Specchia F. Maggioli Editore, Santarcangelo di Romagna (RN)
  6. Lopalco PL. Efficacia (giudizio professionale, EBM, EBP), in Manuale critico di sanità pubblica. 2015. A cura di Calamo-Specchia F. Maggioli Editore, Santarcangelo di Romagna (RN)




Articles in peer-reviewed journals 

  1. Lopalco PL, Tan L. Pandemic vaccines: Are we prepared for the next pandemic? Future Virol. 2016;11(4):253-258. doi:10.2217/fvl-2016-0020.
  2. Lopalco PL. European decision-maker perspective with regard to influenza prevention policies. J Prev Med Hyg. 2016;57(1):E5-8.
  3. Esposito S, Bonanni P, Maggi S, Tan L, Ansaldi F, Lopalco PL, Dagan R, Michel JP, van Damme P, Gaillat J, Prymula R, Vesikari T, Mussini C, Frank U, Osterhaus A, Celentano LP, Rossi M, Guercio V, Gavazzi G. Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid). Hum Vaccin Immunother. 2016;12(7):1777-94. doi: 10.1080/21645515.2016.1150396.
  4. Tozzi AE, Gesualdo F, D’Ambrosio A, Pandolfi E, Agricola E, Lopalco PL. Can Digital Tools Be Used for Improving Immunization Programs? Front Public Health. 2016; 4:36. doi: 10.3389/fpubh.2016.00036. eCollection 2016
  5. Hanquet G, Stefanoff P, Hellenbrand W, Heuberger S, Lopalco P, Stuart JM. Strong Public Health Recommendations from Weak Evidence? Lessons Learned in Developing Guidance on the Public Health Management of Meningococcal Disease. Biomed Res Int. 2015; 2015:569235. doi: 10.1155/2015/569235. Epub 2015 Nov 26. Review.
  6. Di Mario S, Basevi V, Lopalco PL, Balduzzi S, D’Amico R, Magrini N. Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV. J Immunol Res. 2015; 2015:435141. doi: 10.1155/2015/435141. Epub 2015 Aug 25. Review.
  7. Severi E, Vennema H, Takkinen J, Lopalco PL, Coulombier D. Hepatitis A outbreaks. Lancet Infect Dis. 2015 Jun;15(6): 632-4. doi: 10.1016/S1473-3099(15)00021-3. Epub 2015 May 17.
  8. Nijsten DRE, Carrillo-Santisteve P, Miglietta A, Ruitenberg J, Lopalco PL. Is EU/EEA population protected from polio? Human Vaccines & Immunotherapeutics, 2015; 11:9, 2123-2131, DOI: 10.1080/21645515.2015.1016673
  9. Suk JE, Lopalco P, Pastore Celentano L. Hesitancy, Trust and Individualism in Vaccination Decision-Making. PLOS Currents Outbreaks. 2015 Feb 25. Edition 1. doi: 10.1371/currents.outbreaks.49dba84ad4146de33706b1f131d7caa3
  10. Navarro-Torné A, Dias JG, Hruba F, Lopalco PL, Pastore-Celentano L, Gauci AJ; Invasive Pneumococcal Disease Study Group. Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis. 2015; (3):417-25. DOI: 10.3201/eid2103.140634
  11. Stillo M, Carrillo Santisteve P, Lopalco PL. Safety of human papillomavirus vaccines: a review. Expert Opin Drug Saf. 2015;14(5):697-712. doi: 10.1517/14740338.2015.1013532
  12. Lopalco PL, DeStefano F. The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines. Vaccine. 2014; doi: 10.1016/j.vaccine.2014.10.047. [Epub ahead of print] Review.
  13. Navarro Torné A, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJ, Pastore-Celentano L; ECDC country experts for pneumococcal disease. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. Vaccine. 2014;32(29):3644-50. Epub 2014 May 2.
  14. Mereckiene J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber J, D’Ancona F, Levy-Bruhl D, Dematte L, Giambi C, Valentiner-Branth P, Stankiewicz I, Appelgren E, O Flanagan D; VENICE project gatekeepers group. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill. 2014; 19(16): 20780.
  15. Colzani E, McDonald SA, Carrillo-Santisteve P, Busana MC, Lopalco P, Cassini A. Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011. Vaccine. 2014; 32(16):1814-9. doi: 10.1016/j.vaccine.2014.01.094. Epub 2014 Feb 13.
  16. Carrillo-Santisteve P, Lopalco PL. Varicella vaccination: a laboured take-off. Clin Microbiol Infect. 2014; 20 Suppl 5:86-91. 6
  17. Galanakis E, D’Ancona F, Jansen A, Lopalco PL; VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points. The issue of mandatory vaccination for healthcare workers in Europe. Expert Rev Vaccines. 2014 Feb;13(2):277-83. Epub 2013 Dec 18. 2
  18. Kramarz P, Lopalco PL, Huitric E, Pastore Celentano L. Vaccine-preventable diseases: the role of the European Centre for Disease Prevention and Control. Clin Microbiol Infect. 2014. 20 Suppl. 5: 2-6. 6
  19. Lopalco PL, Carrillo Santisteve P. Actual immunization coverage throughout Europe: are existing data sufficient? Clin Microbiol Infect. 2014; 20 Suppl 5:7-116
  20. Celentano LP, Lopalco PL, Huitric E, Coulombier D, Giesecke J. Polio and the risk for the European Union. Lancet. 2014;383(9913):216-7. Epub 2013 Nov 14. 1
  21. Galanakis E, Jansen A, Lopalco PL, Giesecke J. Ethics of mandatory vaccination for healthcare workers. Euro Surveill. 2013;18(45):pii=20627. 5
  22. Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, Scalia Tomba G, Lopalco P, Rizzo C, Merler S, Manfredi P. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One. 2013; 8(4):e60732. 7
  23. Carrillo-Santisteve P, Lopalco PL. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Clin Microbiol Infect. 2012; 18 Suppl 5 :50-6. 6
  24. Simone B, Carrillo-Santisteve P, Lopalco PL. Healthcare workers’ role in keeping MMR vaccination uptake high in Europe: a review of evidence. Euro Surveill. 2012; 17(26):pii=20206.1
  25. Haverkate M, D Ancona F, Giambi C, Johansen K, Lopalco PL, Cozza V, Appelgren E, On Behalf Of The Venice Project Gatekeepers And Contact Points. Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes. Euro Surveill. 2012; 17(22). pii: 20183. No abstract available. 1
  26. Johansen K, Lopalco PL, Giesecke J. Immunisation registers–important for vaccinated individuals, vaccinators and public health. Euro Surveill. 2012; 17(16). pii: 20151. No abstract available. 1
  27. Derrough T, Bacci S, Lopalco PL. Letter to the editor: commitment needed for the prevention of congenital rubella syndrome in Europe. Euro Surveill. 2012; 17(10). pii: 20106. No abstract available. 1
  28. Mereckiene J, Cotter S, Weber JT, Nicoll A, D’Ancona F, Lopalco PL, Johansen K, Wasley AM, Jorgensen P, Lévy-Bruhl D, Giambi C, Stefanoff P, Dematte L, O’Flanagan D; VENICE project gatekeepers group. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill. 2012; 17(4). pii: 20064. 1
  29. Carrillo-Santisteve P, Ciancio BC, Nicoll A, Lopalco PL. The importance of influenza prevention for public health. Hum Vaccin Immunother. 2012; 8(1):89-95. Epub 2012 Jan 1. 6
  1. Lopalco PL, Sprenger M. Do European doctors support measles, mumps, rubella vaccination programmes enough? Euro Surveill. 2011; 16(39). pii: 19979. 6.1
  2. Haverkate M, D’Ancona F, Johansen K, van der Velden K, Giesecke J, Lopalco PL. Assessing vaccination coverage in the European Union: is it still a challenge? Expert Rev Vaccines. 2011; 10(8): 1195-205. 4.1
  3. Kunze U; Lopalco PL as member of ISW TBE. Tick-borne encephalitis: new paradigms in a changing vaccination environment. Wien Med Wochenschr. 2011; 161(13-14): 361-4.
  4. Traversa G, Spila-Alegiani S, Bianchi C, Ciofi degli Atti M, Frova L, Massari M, Raschetti R, Salmaso S, Scalia Tomba G; Lopalco PL as part of the Hera Study Group. Sudden unexpected deaths and vaccinations during the first two years of life in Italy: a case series study. PLoS One. 2011; 6(1): e16363. 4.3
  5. Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM. Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer. 2011; 128(12):2765-74. Epub 2011 Mar 25. 4.7
  6. Stefanoff P, Polkowska A, Giambi C, Levy-Bruhl D, O’Flanagan D, Dematte L, Lopalco PL, Mereckiene J, Johansen K, D’Ancona F; VENICE project gatekeepers, contact persons group. Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations. Vaccine. 2011; 29(6): 1283-8. Epub 2010 Dec 9. 3.6
  7. Steffens I, Martin R, Lopalco P. Spotlight on measles 2010: measles elimination in Europe – a new commitment to meet the goal by 2015. Euro Surveill. 2010;15(50). pii: 19749.
  8. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O’Flanagan D, Lopalco PL, D’Ancona F, Levy-Bruhl D; VENICE 2 project gatekeepers group. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill. 2010; 15(47). pii: 19730.
  9. Mereckiene J, Cotter S, D’Ancona F, Giambi C, Nicoll A, Levy-Bruhl D, Lopalco PL, Weber JT, Johansen K, Dematte L, Salmaso S, Stefanoff P, Greco D, Dorleans F, Polkowska A, O’Flanagan D; VENICE project gatekeepers group.             Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill. 2010 Nov 4;15(44). pii: 19700.
  10. Lopalco PL. Childhood pneumococcal vaccination in Europe. J Prev Med Hyg. 2009 Dec;50(4):197-200.
  11. Martinelli D, Bitetto I, Tafuri S, Lopalco PL, Mininni RM, Prato R. Control of hepatitis A by universal vaccination of children and adolescents: An achieved goal or a deferred appointment? Vaccine. 2010 Aug 2. [Epub ahead of print] PubMed PMID: 20688041. 3.6
  12. Lopalco PL, Martin R. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Euro Surveill. 2010 Apr 29;15(17). pii: 19557. PubMed PMID: 20460089.
  13. Mereckiene J, Cotter S, Lopalco PL, D’Ancona F, Levy-Bruhl D, Giambi C, Johansen K, Dematte L, Salmaso S, Stefanoff P, O’Flanagan D. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009? Vaccine. 2010 Jun 17;28(28):4470-7. Epub 2010 May 6. PubMed PMID: 20451643. 3.6
  14. Lopalco PL, Johansen K, Ciancio B, De Carvalho Gomes H, Kramarz P, Giesecke J. Monitoring and assessing vaccine safety: a European perspective. Expert Rev Vaccines. 2010 Apr;9(4):371-80. PubMed PMID: 20370548. 4.2
  15. Kunze U; ISW TBE. Tick-borne encephalitis: from childhood to golden age does increased mobility mean increased risk? Conference report of the 11th meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Vaccine. 2010 Jan 22;28(4):875-6. Epub 2009 Nov 27. PubMed PMID: 19945411. 3.6
  16. Martinelli D, Mincuzzi A, Minerba S, Tafuri S, Conversano M, Caputi G, Lopalco PL, Quarto M, Germinario C, Prato R. Malignant cancer mortality in Province of Taranto (Italy). Geographic analysis in an area of high environmental risk. J Prev Med Hyg. 2009 Sep;50(3):181-90. PubMed PMID: 20411653.
  17. Lévy-Bruhl D, Bousquet V, King LA, O’Flanagan D, Bacci S, Lopalco PL, Salmaso S; country specific VENICE gate keepers and contact points. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey. Eur J Cancer. 2009;45(15):2709-13. Epub 2009 Aug 18. 4.1
  18. Lopalco PL, de Carvalho HG, Kreidl P, Leitmeyer K, Giesecke J. Childhood vaccination schedules in Europe vary widely. Is this a problem? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Nov ;52(11):1095-8. PubMed PMID: 19756336.
  19. Tafuri S, Martinelli D, Caputi G, Arbore A, Lopalco PL, Germinario C, Prato R. An audit of vaccination coverage among vaccination service workers in Puglia, Italy. Am J Infect Control. 2009;37(5):414-6. Epub 2009 Feb 12. 3.0
  20. De Carvalho Gomes H, Muscat M, Monnet DL, Giesecke J, Lopalco PL. Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007. Euro Surveill. 2009;14(12). pii: 19159.
  21. Marchetti F, Assael B, Gabutti G, Guarino A, Lopalco PL, Marocco A, Ruggeri F, Titone L, Tozzi A, Rosati GV, Zotti C, Franco E. Monitoring the rate of hospitalization before rotavirus immunization in Italy utilizing ICD9-CM regional databases. Hum Vaccin. 2009;5(3):172-6. Epub 2009 Mar 10.
  22. Tafuri S, Prato R, Martinelli D, Calvario A, Bozzi A, Labianca M, Patti A, Lopalco PL, Germinario C. Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia
  1. (Southern Italy). BMC Infect Dis. 2008;8:150. 6
  1. King LA, Lévy-Bruhl D, O’Flanagan D, Bacci S, Lopalco PL, Kudjawu Y, Salmaso S; VENICE Country Specific Gate Keepers and Contact Points. Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey. Euro Surveill. 2008;13(33).
  2. van de Laar MJ, Lopalco PL. World Hepatitis Day: a timely reminder of the challenges ahead. Euro Surveill. 2008;13(21).
  3. Manissero D, Lopalco PL, Levy-Bruhl D, Ciofi Degli Atti ML, Giesecke J. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings. Vaccine. 2008;26(18):2253-9. Epub 2008 Mar 11. 3.6
  4. Kreidl P, Gomes H, Lopalco PL, Hagmaier K, Pastore Celentano L, Vasconcelos P, Yilmaz C. European Immunization Week 2008–time for reflection. Euro Surveill. 2008;13(16).
  5. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E; National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008; m46(6):868-75. 8.2
  6. Lopalco PL. Is there room for improving case management for contacts of meningococcal disease in the European Union? Euro Surveill. 2008;13(10).
  7. Lopalco PL, Prato R, Chironna M, Germinario C, Quarto M. Control of hepatitis A by universal vaccination of adolescents, Puglia, Italy. Emerg Infect Dis. 2008;14(3):526-8. 6.8
  8. Hamers FF; European Centre for Disease Prevention and Control. European Centre for Disease Prevention and Control issues guidance for the introduction of human papillomavirus (HPV) vaccines in European Union countries. Euro Surveill. 2008;13(4).
  9. Prato R, Martinelli D, Fusco A, Panebianco A, Lopalco PL, Germinario CA, Quarto M. The perception of healthcare quality of elderly in the city of Bari, South Italy. BMC Health Serv Res. 2007;7:174. 1.7
  10. Chironna M, Prato R, Sallustio A, Martinelli D, Germinario C, Lopalco P, Quarto M. Genetic characterization of measles virus strains isolated during an epidemic cluster in Puglia, Italy 2006-2007. Virol J. 2007;4:90. 2.4
  11. Johansen K, Lopalco P. Passive immunity against measles in infants: is there a need for policy changes in the European vaccination schedules? Euro Surveill. 2007;12(9):E3-4.
  12. Lopalco PL. Measuring the impact of PCV7 in the European Union: why it is a priority. Euro Surveill. 2007;12(6):E070614.6.
  13. Tosti ME, Mariano A, Spada E, Pizzuti R, Gallo G, Ragni P, Zotti C, Lopalco P, Curtale F, Graziani G, Mele A, Stroffolini T; Sistema Epidemiologico Integrato dell’Epatite Virale Acuta Collaborating Group. Incidence of parenterally transmitted acute viral hepatitis among healthcare workers in Italy. Infect Control Hosp Epidemiol. 2007;28(5):629-32. Epub 2007 Apr 12.
  14. Kudjawu Y, Lévy-Bruhl D, Celentano LP, O’Flanagan D, Salmaso S, Lopalco P, Mullins N, Bacci S; VENICE working group. The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU–preliminary results of a VENICE survey. Euro Surveill. 2007;12(4):E070426.1.
  15. Pastore Celentano L, Lopalco PL, O’Flanagan D, Levy-Bruhl D, Ferro A, Tridente G, Appelgren E, Salmaso S. Venice: Europe’s new network for vaccination. Euro Surveill. 2007;12(1):E070118.3.
  16. Lopalco PL, Giesecke J. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe. Euro Surveill. 2007;12(1):E070118.1.
  17. Lopalco PL; Editorial team. Use of 7-valent pneumococcal conjugate vaccine in EU. Euro Surveill. 2006;11(12):E061207.3.
  18. Mele A, Mariano A, Tosti ME, Stroffolini T, Pizzuti R, Gallo G, Ragni P, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E; SEIEVA Collaborating Group. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Clin Infect Dis. 2007 Feb 1;44(3):e17-24. Epub 2006 Dec 22. 8.2
  19. Lopalco P,  Lévy-Bruhl D,  Salmaso S,  Pastore Celentano L,  Ferro A,  Tridente G,  Appelgren E,  O’Flanagan D.  VENICE: Europe’s new network for vaccination. Euro Surveill 2007;12(1):E070118.3
  20. Lopalco PL, Giesecke J. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe. Euro Surveill. 2007 Jan 18; 12(1): E070118.1
  21. Lopalco PL; Editorial team. Use of 7-valent pneumococcal conjugate vaccine in EU. Euro Surveill. 2006 Dec 7;11(12):E061207.3.
  22. Prato R, Lopalco PL, Chironna M, Germinario C, Quarto M. An outbreak of hepatitis A in Southern Italy: the case for vaccinating food handlers. Epidemiol Infect. 2006 Aug;134(4):799-802. 2.4
  23. Marocco A, Assael B, Gabutti G, Guarino A, Lopalco PL, Marchetti F, Ruggeri FM, Titone L, Tozzi AE, Vitali Rosati G, Zotti C, Franco E. [Hospitalisation associated with Rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes] Ig Sanita Pubbl. 2006 Mar-Apr;62(2):215-44. Italian.
  24. Giannelli G, Minchella L, Lopalco PL, Mastromarco G, Antonaci S. Treatment of community-acquired pneumonia: a descriptive study in an Apulian department of internal medicine. Med Sci Monit. 2005 Sep;11(9):CR434-9.
  25. Prato R, Germinario C, Pastore R, Napoli C, Squicciarini R, Lopalco PL. [Hospitalisations for cataract surgery in Puglia 2000-2002] Ig Sanita Pubbl. 2005 May-Jun;61(3):249-59. Italian.
  26. Lopalco PL, Malfait P, Menniti-Ippolito F, Prato R, Germinario C, Chironna M, Quarto M, Salmaso S. Determinants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periods. J Viral Hepat. 2005 May;12(3):315-21. 3.3
  27. D’Ancona F, Salmaso S, Barale A, Boccia D, Lopalco PL, Rizzo C, Monaco M, Massari M, Demicheli V, Pantosti A; Italian PNC-Euro working group. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine. 2005 Mar 31;23(19):2494-500. 3.6
  28. Prato R, Germinario C, Pastore R, Greco P, Sanguedolce A, Lopalco PL. [Opinions of women regarding a planned home birth project in Apulia (Southern Italy)] Ann Ig. 2005 Mar-Apr;17(2):129-38. Italian.
  29. Prato R, Lopalco PL, Germinario C.  [An assessment of supply and demand for hip arthroplasty procedures in Puglia (Italy) in the years 1996-2003] Ig Sanita Pubbl. 2005 Mar-Apr;61(2):133-48. Italian.
  30. Sagliocca L, Bianco E, Amoroso P, Quarto M, Richichi I, Tosti ME, Carannante N, Chironna M, Chiriaco P, Di Bari G, Lopalco P, Resta F, Santantonio T, Tantimonaco G, Mele A. Feasibility of vaccination in preventing secondary cases of hepatitis A virus infection. Vaccine. 2005 Jan 4;23(7):910-4. 3.6
  31. Mariano A, Mele A, Tosti ME, Parlato A, Gallo G, Ragni P, Zotti C, Lopalco P, Pompa MG, Graziani G, Stroffolini T. Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. J Med Virol. 2004 Oct;74(2):216-20. 2.5
  32. Prato R, Lopalco PL, Chironna M, Barbuti G, Germinario C, Quarto M. Norovirus gastroenteritis general outbreak associated with raw shellfish consumption in south Italy. BMC Infect Dis. 2004 Sep 21;4:37. 2.6
  33. Germinario C, Semisa D, Picoco F, Prato R, Lopalco PL, Quarto M. [Psychiatric residential care facilities in the Puglia region. Phase 1 results of the progres project] Ig Sanita Pubbl. 2004 Sep-Oct;60(5):311-24. Italian.
  34. Chironna M, Lopalco P, Prato R, Germinario C, Barbuti S, Quarto M. Outbreak of infection with hepatitis A virus (HAV) associated with a foodhandler and confirmed by sequence analysis reveals a new HAV genotype IB variant. J Clin Microbiol. 2004 Jun;42(6):2825-8. 4.2
  35. Prato R, Napoli C, Barbuti G, Germinario C, Lopalco PL. [General practitioners and mandatory surveillance of communicable diseases: a descriptive study in Puglia (South Italy)] Ann Ig. 2004 May-Jun;16(3):449-55. Italian.
  36. Mastrolonardo M, Diaferio A, Vendemiale G, Lopalco P. Seborrhoeic dermatitis in the elderly: inferences on the possible role of disability and loss of self-sufficiency. Acta Derm Venereol. 2004;84(4):285-7.
  37. Stroffolini T, Bianco E, Szklo A, Bernacchia R, Bove C, Colucci M, Cristina Coppola R, D’Argenio P, Lopalco P, Parlato A, Ragni P, Simonetti A, Zotti C, Mele A. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine. 2003 Mar 7;21(11-12):1246-9. 3.6
  38. Bianco E, Stroffolini T, Spada E, Szklo A, Marzolini F, Ragni P, Gallo G, Balocchini E, Parlato A, Sangalli M, Lopalco PL, Zotti C; SEIEVA Collaborating Group. Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. Digest Liver Dis. 2003 Jun;35(6):404-8. 3.0
  39. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Immunity to diphtheria among refugees in southern Italy. Vaccine. 2003 Jul 4;21(23):3157-61. 3.6
  40. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection. 2003 Mar;31(2):70-4. 2.0
  41. Gabutti G, Fedele A, Aprile V, Guido M, Lopalco P. Immigration flows and new epidemiological evidence in southern Italy. Vaccine. 2003 Jan 17;21(5-6):399-400. 3.6
  42. Prato R, Labianca M, Calvario A, Bozzi A, Rizzo C, Fiore L, Vellucci L, Buttinelli G, Donati V, Lopalco PL, Germinario C. [Evaluation of the Surveillance System of Acute Flaccid Paralysis in Puglia: 5 years of work] Ann Ig. 2002 Nov-Dec;14(6):487-94. Italian.
  43. Lopalco PL, Germinario C, Prato R, Rizzo C, Chironna M, Quarto M. [Comparative evaluation of 2 epidemiologic surveillance systems of hepatitis A] Ann Ig. 2002 Nov-Dec;14(6):459-64. Italian.
  44. Ciccozzi M, Tosti ME, Gallo G, Ragni P, Zotti C, Lopalco P, Ara G, Sangalli M, Balocchini E, Szklo AS, Mele A; SEIEVA collaborating group. Risk of hepatitis A infection following travel. J Viral Hepatitis. 2002 Nov;9(6):460-5. 3.3
  45. Mastrolonardo M, Lopalco PL, Diaferio A. Topical immunotherapy with contact sensitizers: a model to study the natural history of delayed hypersensitivity. Contact Dermatitis. 2002 Oct;47(4):210-4. 3.6
  46. Germinario C, Lopalco PL, Prato R, Quarto M. [Target of the anti-varicella vaccine] Ann Ig. 2002 Jul-Aug;14(4 Suppl 6):55-8. Italian.
  47. Prato R, Germinario C, Mastrogiacomo MG, Lepore V, Lopalco PL. [Hospitalisations for vertebral fractures in Apulia during 1998-2000] Ig Sanita Pubbl. 2002 Jul-Aug;58(4):241-52. Italian.
  48. Quarto M, Chironna M, Lopalco PL, Carrozzini F, Germinario C. [Demographic changes and migrations: influence on immunization strategy] Ann Ig. 2002 May-Jun;14(3 Suppl 3):33-9. Italian.
  49. Lopalco PL, Prato R, Germinario C. [Typhoid fever: from parenteral to oral vaccines] Ann Ig. 2002 May-Jun;14(3 Suppl 3):27-32. Italian.
  50. Spada E, Mele A, Ciccozzi M, Tosti ME, Bianco E, Szklo A, Ragni P, Gallo G, Balocchini E, Sangalli M, Lopalco PL, Moiraghi A, Stroffolini T; SEIEVA collaborating group. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Digest Liver Dis. 2001 Dec;33(9):778-84. 3.0
  51. Di Stefano M, Favia A, Monno L, Lopalco P, Caputi O, Scardigno AC, Pastore G, Fiore JR, Angarano G. Intracellular and cell-free (infectious) HIV-1 in rectal mucosa. J Med Virol. 2001 Dec;65(4):637-43. 2.5
  52. Gabutti G, Germinario C, Lai P, De Luca S, Maiorano M, Tanzarella C, Lopalco PL, Donatelli I, Quarto M; Collaborativo per la sorveglianza dell’influenza. [Epidemiologic and virologic surveillance of flu in Puglia] Ann Ig. 2001 Nov-Dec;13(6):503-12. Italian.
  53. Mele A, Spada E, Sagliocca L, Ragni P, Tosti ME, Gallo G, Moiraghi A, Balocchini E, Sangalli M, Lopalco PL, Stroffoli T. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol. 2001 Aug;35(2):284-9. 7.8
  54. Lopalco PL, Germinario C, Prato R, Quarto M. [Pneumococcal vaccine in the Puglia region] Ann Ig. 2001 Jul-Aug;13(4 Suppl 3):13-8. Italian. No abstract available.
  55. Germinario C, Fanelli M, Chironna M, Lopalco PL, Serio G, Quarto M. [Occupational risk for HIV and HBV: KAP survey in a sample of dentists] Ann Ig. 2001 Jul-Aug;13(4):281-90. Italian.
  56. Vella FS, Orlando P, Attanasi F, Simone B, Mundo A, Lopalco P, Schiraldi O, Antonaci S. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?] Recenti Prog Med. 2001 Feb;92(2):107-12. Italian.
  57. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Quarto M. Prevalence of hepatitis virus infections in Kosovar refugees. Int J Infect Dis. 2001;5(4):209-13. 2.2
  58. Vimercati A, Greco P, Lopalco P, Loizzi V, Scioscia M, Mei L, Rossi AC, Selvaggi L. The value of ultrasonographic examination of the uterine cervix in predicting post-term pregnancy. J Perinat Med. 2001;29(4):317-21. 1.7
  59. Lopalco PL, Salleras L, Barbuti S, Germinario C, Bruguera M, Buti M, Dominguez A. Hepatitis A and B in children and adolescents–what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine. 2000 Oct 15;19(4-5):470-4. 3.6
  60. Chironna M, Germinario C, Lopalco PL, Quarto M, Barbuti S. HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region). Epidemiol Infect. 2000 Aug;125(1):163-7. 2.4
  61. D’Alessandro D, Bellante De Martiis G, Germinario C, Lopalco PL, Mura I, Orsi GB, Pasquarella C, Privitera G, Proietti C, Reali D, Savino A, Vescia N. [The use of disinfectants in the domestic environment] Ann Ig. 2000 May-Jun;12(3):247-54. Italian.
  62. Lopalco PL, Germinario C, Di Martino V, Frisoli L, Pagano A, Quarto M, Barbuti S. [Epidemiologic study and cost analysis of an Salmonella enteritidis epidemic] Ann Ig. 2000 Jul-Aug;12(4):279-85. Italian.
  63. Comodo N, Nastasi A, Bonaccorsi G, Barbuti S, Lopalco PL, Bonanni P, Poli A, Paladini A, Peracca L, Bussotti A, Liverani L. [The present and future of infections in the domestic environment in Italy] Ann Ig. 2000 May-Jun;12(3):233-7. Italian.
  64. Vimercati A, Greco P, Loverro G, Lopalco PL, Pansini V, Selvaggi L. Maternal complications after caesarean section in HIV infected women. Eur J Obstet Gynecol Reprod Biol. 2000 May;90(1):73-6. 1.6
  65. Vimercati A, Greco P, Lopalco PL, Loverro G, Fiore JR, Bettocchi S, Angarano G, Selvaggi L. Immunological markers in HIV-infected pregnant and non-pregnant women. Eur J Obstet Gynecol Reprod Biol. 2000 May;90(1):37-41. 1.6
  66. Lopalco PL, Germinario C, Calvario A, Chironna M, Quarto M, Barbuti S.  High level of immunity against poliomyelitis in Albanian refugees in southern Italy. J Travel Med. 2000 May-Jun;7(3):111-5. 1.5
  67. Germinario C, Chironna M, Quarto M, Lopalco P, Calvario A, Barbuti S. Immunosurveillance on Kosovar children refugees in Southern Italy. Vaccine. 2000 Apr 14;18(20):2073-4. 3.6
  68. Germinario C, Lopalco PL, Chirona M, Da Villa G. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience. Vaccine. 2000 Feb 18;18 Suppl 1:S83-5.  3.6
  69. Fiore JR, Laddago V, Lepera A, La Grasta L, Di Stefano M, Saracino A, Lopalco P, Pastore G, Angarano G. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding. New Microbiol. 2000 Jan;23(1):85-92. 0.9
  70. Patti AM, Santi AL, Bellucci C, Ciapetti C, Fara GM, Germinario C, Calvario A, Lopalco PL, Barbuti S, Tanzi ML, Affanni P, Nieddu A, Bellelli E, Vellucci L, Caraffa De Stefano D. Serological survey on immunity status against polioviruses in Italian young adults and in immigrants. Ann Ig. 1999 Sep-Oct;11(5):353-9.
  71. Chironna M, Germinario C, Lopalco P, Quarto M. Lack of HIV infection in Albanians immigrated into southern Italy in 1997. Eur J Epidemiol. 1999 Jul;15(6):591-2. 3.7
  72. Arcieri R, Dionisi AM, Caprioli A, Lopalco P, Prato R, Germinario C, Rizzo C, Larocca AM, Barbuti S, Greco D, Luzzi I. Direct detection of Clostridium perfringens enterotoxin in patients’ stools during an outbreak of food poisoning. FEMS Immunol Med Mic. 1999 Jan;23(1):45-8. 2.3
  73. Lopalco PL, Malfait P, Salmaso S, Germinario C, Quarto M, Barbuti S, Cipriani R, Mundo A, Pesole G. A persisting outbreak of hepatitis A in Puglia, Italy, 1996: epidemiological follow-up. Euro Surveill. 1997 Apr;2(4):31-32.
  74. Quarto M, Chironna M, Germinario C, Lopalco PL, Barbuti S. [Prevalence of HTLV-I and HTLV-II infection in Puglia] Ann Ig. 1996 Nov-Dec;8(6):649-55. Italian.
  75. Malfait P, Lopalco PL, Salmaso S, Germinario C, Salamina G, Quarto M, Barbuti S, Cipriani R, Mundo A, Pesole G. An outbreak of hepatitis A in Puglia, Italy, 1996. Euro Surveill. 1996 May;1(5):33-35.
  76. Lopalco PL, Germinario C, Quarto M, Barbuti S. [Mandatory and non-mandatory vaccinations in childhood: estimation of vaccination coverage in Apulia] Ann Ig. 1995 Nov-Dec;7(6):401-8. Italian.
  77. Germinario C, Quarto M, Lopalco PL, Sanguedolce A. [Pertussis vaccination: results of a KAP study of Apulia mothers] Ann Ig. 1993 Jul-Aug;5(4):253-8. Italian.
  78. Lucivero G, D’Addario V, Tannoia N, Dell’Osso A, Gambatesa V, Lopalco PL, Cagnazzo G. Ontogeny of human lymphocytes. Two-color fluorescence analysis of circulating lymphocyte subsets in fetuses in the second trimester of pregnancy. Fetal Diagn Ther. 1991;6(3-4):101-6. 0.9

Università di Pisa
Lungarno Pacinotti 43, 56126 Pisa
P.I. 00286820501
C.F. 80003670504

Servizio a cura del
SIA - Sistema Informatico di Ateneo

Torna in cima